Literature DB >> 6192088

Lyme disease spirochetes and ixodid tick spirochetes share a common surface antigenic determinant defined by a monoclonal antibody.

A G Barbour, S L Tessier, W J Todd.   

Abstract

Ixodid tick-associated spirochetes have been implicated as the etiological agents of Lyme disease. We raised a murine monoclonal antibody (H5332) against a spirochete, strain B31, isolated from Ixodes dammini ticks. In indirect immunofluorescence assays and western blot analyses, H5332 reacted with whole cells or isolated components of not only strain B31 but also spirochetes isolated from Ixodes ricinus ticks, a field mouse, a raccoon, and patients with Lyme disease. In contrast, H5332 did not bind to representative borreliae, treponemes, and leptospires. Using indirect immunofluorescence assays and immune electron microscopy, we found the H5332 determinant to be diffusely distributed over the surface of prefixed spirochetes but to be aggregated in patches when the organisms were incubated with H5332 and a second ligand before fixation. Radioimmunoprecipitation and western blot studies revealed the H5332 determinant to be either on or tightly associated with an abundant outer membrane protein with an apparent subunit molecular weight of 31,000.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6192088      PMCID: PMC264710          DOI: 10.1128/iai.41.2.795-804.1983

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  30 in total

1.  Rapid isolation of antigens from cells with a staphylococcal protein A-antibody adsorbent: parameters of the interaction of antibody-antigen complexes with protein A.

Authors:  S W Kessler
Journal:  J Immunol       Date:  1975-12       Impact factor: 5.422

2.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

Review 3.  Anatomy and chemistry of spirochetes.

Authors:  S C Holt
Journal:  Microbiol Rev       Date:  1978-03

4.  Normal distribution, patching and capping of lymphocyte surface immunoglobulin studied by electron microscopy.

Authors:  S de Petris; M C Raff
Journal:  Nat New Biol       Date:  1973-02-28

5.  Neurologic abnormalities of Lyme disease.

Authors:  L Reik; A C Steere; N H Bartenhagen; R E Shope; S E Malawista
Journal:  Medicine (Baltimore)       Date:  1979-07       Impact factor: 1.889

6.  A film detection method for tritium-labelled proteins and nucleic acids in polyacrylamide gels.

Authors:  W M Bonner; R A Laskey
Journal:  Eur J Biochem       Date:  1974-07-01

7.  Erythema chronicum migrans and Lyme arthritis. The enlarging clinical spectrum.

Authors:  A C Steere; S E Malawista; J A Hardin; S Ruddy; W Askenase; W A Andiman
Journal:  Ann Intern Med       Date:  1977-06       Impact factor: 25.391

8.  Lyme arthritis: an epidemic of oligoarticular arthritis in children and adults in three connecticut communities.

Authors:  A C Steere; S E Malawista; D R Snydman; R E Shope; W A Andiman; M R Ross; F M Steele
Journal:  Arthritis Rheum       Date:  1977 Jan-Feb

9.  Two distinct mechanisms for redistribution of lymphocyte surface macromolecules. I. Relationship to cytoplasmic myosin.

Authors:  J Braun; K Fujiwara; T D Pollard; E R Unanue
Journal:  J Cell Biol       Date:  1978-11       Impact factor: 10.539

10.  Studies on the mechanism of phagocytosis. II. The interaction of macrophages with anti-immunoglobulin IgG-coated bone marrow-derived lymphocytes.

Authors:  F M Griffin; J A Griffin; S C Silverstein
Journal:  J Exp Med       Date:  1976-09-01       Impact factor: 14.307

View more
  213 in total

1.  Validity of interpretation criteria for standardized Western blots (immunoblots) for serodiagnosis of Lyme borreliosis based on sera collected throughout Europe.

Authors:  U Hauser; G Lehnert; B Wilske
Journal:  J Clin Microbiol       Date:  1999-07       Impact factor: 5.948

2.  In vitro and in vivo neutralization of the relapsing fever agent Borrelia hermsii with serotype-specific immunoglobulin M antibodies.

Authors:  A G Barbour; V Bundoc
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

3.  Borrelia burgdorferi population dynamics and prototype gene expression during infection of immunocompetent and immunodeficient mice.

Authors:  Emir Hodzic; Sunlian Feng; Kim J Freet; Stephen W Barthold
Journal:  Infect Immun       Date:  2003-09       Impact factor: 3.441

4.  The relapsing fever agent Borrelia hermsii has multiple copies of its chromosome and linear plasmids.

Authors:  T Kitten; A G Barbour
Journal:  Genetics       Date:  1992-10       Impact factor: 4.562

5.  Laboratory confirmation of Lyme disease.

Authors:  T G Schwan; W J Simpson; P A Rosa
Journal:  Can J Infect Dis       Date:  1991

6.  Comparison of an indirect fluorescent-antibody test with an enzyme-linked immunosorbent assay for serological studies of Lyme disease.

Authors:  L A Magnarelli; J M Meegan; J F Anderson; W A Chappell
Journal:  J Clin Microbiol       Date:  1984-08       Impact factor: 5.948

7.  Subcellular localization and chaperone activities of Borrelia burgdorferi Hsp60 and Hsp70.

Authors:  A Scopio; P Johnson; A Laquerre; D R Nelson
Journal:  J Bacteriol       Date:  1994-11       Impact factor: 3.490

8.  Concurrent Borrelia burgdorferi and Babesia microti infection in nymphal Ixodes dammini.

Authors:  J Piesman; T N Mather; S R Telford; A Spielman
Journal:  J Clin Microbiol       Date:  1986-09       Impact factor: 5.948

9.  Functional Equivalence of OspA and OspB, but Not OspC, in Tick Colonization by Borrelia burgdorferi.

Authors:  Kit Tilly; Aaron Bestor; Patricia A Rosa
Journal:  Infect Immun       Date:  2016-04-22       Impact factor: 3.441

10.  Seasonal prevalence of Borrelia burgdorferi in natural populations of white-footed mice, Peromyscus leucopus.

Authors:  J F Anderson; R C Johnson; L A Magnarelli
Journal:  J Clin Microbiol       Date:  1987-08       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.